President and CEO of Leo Pharma Catherine Mazzacco has led the company in the development of a new capital and governance structure, and according to a press statement, the CEO and board of directors have "concluded that this would be the right time for LEO Pharma to recruit a new CEO."
"On behalf of the Board, I would like to express our sincere thanks to Catherine Mazzacco for her commendable efforts in leading the transformation of LEO Pharma towards a leadership position in the innovative space of medical dermatology. Catherine Mazzacco has been instrumental in driving the company’s ambitious growth strategy towards 2030," Chairman of the Board Jesper Brandgaard says in the press release.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Fruergaard leveraging experience from Danish partnerships in key roles in Brussels
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.
Stallergenes slapped with injunction
There are still issues with Stallergenes Greer’s factory in Antony, the Agence Nationale de Sécurité du Médicament has concluded.
Overview: Pharma giants and Bavarian Nordic fight over billion-dollar vaccine market
There is currently no approved vaccine for RSV, which causes serious illness and can be deadly for newborns and the elderly. The race to come first to the vaccine market is heating up, while more companies are close to completing phase III studies. Get an overview of their progress here.
Eargo raises USD 100m from investment firm
US-based Eargo, which is run by a Dane, has entered an agreement with an investment firm which is injecting USD 100m into the company.
US authorities expand monkeypox vaccine plan
More Americans will be offered a monkeypox vaccine.
Global Learning Specialist 
Senior Clinical Trial Disclosure Associate 
Specialist within CMC, Regulatory Affairs Life Cycle Management 
Regulatory Affairs Manager - Maternity Cover 
Project Mgr for Medical Device Development 
QA Senior Specialist 
Director Regulatory Affairs 
Quality Management System Compliance Department Manager 
Device Associate Director/Senior Project Leader 
KLIFO is looking for a Project Director for our office in Denmark or Germany or Sweden 
Clinical Project Leader/ Sr. Clinical Trial Manager – make a difference and join our mission to bring our IL-22 lead program to patients 
Biomarker Operations Lead 
Principal Scientist – Pharmacology